Positron Files all Financial Reports and Announces the Company is Current with its OTC Reporting & Disclosures

Niagara Falls, NY – October 29, 2021 (GLOBE NEWSWIRE) -- Positron Corp (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging company specializing in the field of cardiac Positron... Read More

Positron Announces Timeline for Becoming Current with its OTC Reporting & Disclosures 

Niagara Falls, NY – September 14, 2021 (GLOBE NEWSWIRE) -- Positron Corp (“Positron” or the “Company”) (OTC: POSC) is pleased to announce that Positron has received full OTCIQ access for its filing and approval process with OTC... Read More

Positron Retains Healthcare Advisor I-Square Ventures to Implement Strategy and Expand Market Share

Niagara Falls, NY – July 15, 2021 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC) is pleased to announce today that it has retained the services of I- Square Ventures (“I-Square”)... Read More

April 12, 2021

Re: Q1 2021 Update

Dear Positron Shareholders,

As announced last month we are pleased to have retained Skyline Corporate Communications Group as Positron’s investor relations liaison. Skyline will play a large role in our corporate communication efforts to introduce and inform new, perspective... Read More

Positron Corp Retains Skyline Corporate Communications Group, LLC to Provide Investor Relations Services
Niagara Falls, NY – March 18, 2021 (GLOBE NEWSWIRE) -- Positron Corp (“Positron” or the “Company”) (OTC: POSC) is pleased to announce that it has retained the services of Skyline Corporate Communications Group,... Read More

March 24, 2020

Dear Positron Shareholders,

On behalf of our investors and supporters we are pleased to offer some forward guidance to our business.

The cardiac PET industry is healthy and in the best position we have seen in a decade. A great deal of the industry’s vision and best practices come from the... Read More